Valuation: Virbac

Market Cap 2.85B 3.29B 2.67B 2.43B 4.58B 314B 4.66B 31.27B 12.25B 157B 12.34B 12.07B 524B P/E 2026 *
16.7x
P/E 2027 * 15.1x
Enterprise Value 2.98B 3.43B 2.79B 2.54B 4.78B 327B 4.86B 32.66B 12.8B 164B 12.89B 12.61B 547B EV / Sales 2026 *
1.92x
EV / Sales 2027 * 1.77x
Free-Float
49.03%
Yield 2026 *
0.51%
Yield 2027 * 0.6%
1 day+1.80%
1 week+0.74%
Current month+0.74%
1 month+6.08%
3 months-6.72%
6 months-4.90%
Current year-4.90%
1 week 333
Extreme 333
348.5
1 month 317
Extreme 317
350
Current year 312.5
Extreme 312.5
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap.
22/4/24 Sell

Chief Executive Officer

810 0.0096%
22/4/24 Sell

Chief Executive Officer

140 0.0017%
22/4/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+0.74%+2.56%+18.88% 3.23B
+0.69%-2.27%-48.86%-60.15% 30.92B
+2.02%-11.63%+36.35%+86.01% 11.13B
-1.28%-1.05%-16.14%+3.55% 3.92B
-2.00%+6.87%+59.93%+34.88% 2.26B
-0.14%+1.58%+11.01%+24.03% 1.97B
-0.20%-8.26%+21.28%+124.36% 1.39B
-1.41%+5.23%-16.30%-1.74% 1.24B
-0.90%-0.45%-12.80%-45.15% 1.01B
-0.42%+0.14%-3.49%-22.96% 968M
Average -0.22%+58.63%+3.35%+16.17% 5.8B
Weighted average by Cap. +0.40%+66.94%-17.42%-10.32%

Financials

2026 *2027 *
Net sales 1.55B 1.79B 1.45B 1.32B 2.49B 171B 2.53B 17.02B 6.67B 85.44B 6.72B 6.57B 285B 1.65B 1.9B 1.54B 1.41B 2.65B 181B 2.69B 18.08B 7.08B 90.75B 7.14B 6.98B 303B
Net income 171M 197M 160M 146M 275M 18.83B 280M 1.88B 736M 9.43B 741M 725M 31.45B 190M 219M 177M 162M 305M 20.86B 310M 2.08B 815M 10.44B 821M 803M 34.84B
Net Debt 127M 146M 119M 108M 204M 13.95B 207M 1.39B 545M 6.98B 549M 537M 23.29B 75.16M 86.73M 70.36M 64.2M 121M 8.27B 123M 825M 323M 4.14B 326M 319M 13.81B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
11/08/26 340.00 +1.80% 4,851
10/08/26 €334.00 -3.19% 4,461
07/08/26 €345.00 +0.44% 4,476
06/08/26 €343.50 +1.48% 6,193
05/08/26 €338.50 +0.15% 6,490
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
340.00EUR
Average target price
411.88EUR
Spread / Average Target
+21.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock